[VRTX] YoY Annual Result on 31-Dec-2013 [#FY]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
11-Feb-2014
Financial Year
2013
Quarter
31-Dec-2013 [#FY]
Profit Trend
YoY- -315.79%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Annual Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 1,702,177 1,032,336 580,415 1,211,975 1,527,042 1,410,626 143,370 50.98%
PBT -67,366 -559,581 -734,875 -976,117 -12,381 60,445 -754,626 -33.12%
Tax 16,665 30,381 6,958 -288,567 38,754 19,266 19,275 -2.39%
NP -112,052 -558,115 -738,555 -445,028 -107,032 29,574 -754,626 -27.20%
Tax Rate - - - - - -31.87% - -
Total Cost 1,814,229 1,590,451 1,318,970 1,657,003 1,634,074 1,381,052 897,996 12.42%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -6.58 -54.06 -127.25 -36.72 -7.01 2.10 -526.35 -51.79%
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -0.46 -2.32 -3.14 -1.98 -0.50 0.14 -3.77 -29.55%
EPS Diluted -0.46 -2.31 -3.14 -1.98 -0.50 0.14 -3.77 -29.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.